Celldex Therapeutics Inc (CLDX)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | PHARMACEUTICALS |
| SIC: | IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES |
| CEO: | Anthony S. Marucci |
| Employees: | 205 |
| Web site: | www.celldex.com |
|
| |
-
Formally known as:
- AVANT Immunotherapeutics
| Date | Ratio |
|---|---|
| 2019-02-11 | 1:15 |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
Celldex Therapeutics, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes therapeutic antibodies, antibody drug conjugates, vaccines, and immune system modulators. The company's drug candidates include Glembatumumab vedotin, Varlilumab, CDX-1401, CDX-301, and Rintega. Celldex Therapeutics was founded by Anthony S. Marucci and Tibor Keler in 1983 and is headquartered in Hampton, NJ.
Please log in first to see chart